Article
Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas.
Human pathology - 1 Sept 2015
Liau Jau-Yu, Tsai Jia-Huei, Yang Ching-Yao, Lee Jen-Chieh, Liang Cher-Wei, Hsu Hung-Han, Jeng Yung-Ming
Abstract excerpt
Alternative lengthening of telomeres (ALT) is a mechanism using homologous recombination to maintain telomere length and sustain limitless replicability of cancer cells. Recently, ALT has been found to be associated with inactivation of either α-thalassemia/mental retardation syndrome X-linked (ATRX) or death domain-associated (DAXX) protein. In this study, 119 tumors (88 angiosarcomas, 11 epithelioid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
